- Home
- MDXG vs RDFN Comparison
MDXG vs RDFN Comparison
Compare MDXG & RDFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- RDFN
- Stock Information
- Founded
- MDXG 2006
- RDFN 2002
- Country
- MDXG United States
- RDFN United States
- Employees
- MDXG N/A
- RDFN N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- RDFN Real Estate
- Sector
- MDXG Health Care
- RDFN Finance
- Exchange
- MDXG Nasdaq
- RDFN Nasdaq
- Market Cap
- MDXG 1.3B
- RDFN 1.1B
- IPO Year
- MDXG N/A
- RDFN 2017
- Fundamental
- Price
- MDXG $8.57
- RDFN $7.85
- Analyst Decision
- MDXG Strong Buy
- RDFN Hold
- Analyst Count
- MDXG 5
- RDFN 11
- Target Price
- MDXG $12.00
- RDFN $9.43
- AVG Volume (30 Days)
- MDXG 617.6K
- RDFN 4.4M
- Earning Date
- MDXG 02-26-2025
- RDFN 02-25-2025
- Dividend Yield
- MDXG N/A
- RDFN N/A
- EPS Growth
- MDXG N/A
- RDFN N/A
- EPS
- MDXG 0.52
- RDFN N/A
- Revenue
- MDXG $342,804,000.00
- RDFN $1,016,774,000.00
- Revenue This Year
- MDXG $9.56
- RDFN $8.63
- Revenue Next Year
- MDXG $9.19
- RDFN $9.90
- P/E Ratio
- MDXG $16.49
- RDFN N/A
- Revenue Growth
- MDXG 10.93
- RDFN 3.70
- 52 Week Low
- MDXG $5.47
- RDFN $5.10
- 52 Week High
- MDXG $10.14
- RDFN $15.29
- Technical
- Relative Strength Index (RSI)
- MDXG 41.31
- RDFN 44.93
- Support Level
- MDXG $8.29
- RDFN $7.58
- Resistance Level
- MDXG $9.30
- RDFN $8.78
- Average True Range (ATR)
- MDXG 0.30
- RDFN 0.46
- MACD
- MDXG -0.04
- RDFN 0.06
- Stochastic Oscillator
- MDXG 27.10
- RDFN 22.50
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About RDFN Redfin Corporation
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments and three reportable segments, real estate services, rentals, and mortgage. The company generates the majority of its revenue from Real estate services.